Citation Impact
Citing Papers
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
Multifunctional T-cell Analyses to Study Response and Progression in Adoptive Cell Transfer Immunotherapy
2013 Nobel
Efficient Identification of Mutated Cancer Antigens Recognized by T Cells Associated with Durable Tumor Regressions
2014
Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma
2015
Turning Tumors into Vaccines: Co-opting the Innate Immune System
2013
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cancer nanomedicine: progress, challenges and opportunities
2016 Standout
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Human cancer regression antigens
2013
Tumor Plasticity Interferes with Anti-Tumor Immunity
2014
Effect of age on chronic inflammation and responsiveness to bacterial and viral challenges
2017
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
2013
Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future
2017 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy
2014
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features
2017
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
The biology and function of fibroblasts in cancer
2016 Standout
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
2019
Nasopharyngeal carcinoma
2019 Standout
Vaccines for established cancer: overcoming the challenges posed by immune evasion
2016
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune response
2013
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells
2015
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Impaired gp100-Specific CD8+ T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model
2015
Combined treatment with dabrafenib and trametinib with immune-stimulating antibodies for BRAF mutant melanoma
2015
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
2016
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Identification and validation of novel microenvironment-based immune molecular subgroups of head and neck squamous cell carcinoma: implications for immunotherapy
2018
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors
2016
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
2015
Remodelling the extracellular matrix in development and disease
2014 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
EMT: 2016
2016 Standout
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Cornerstones of CRISPR–Cas in drug discovery and therapy
2016 StandoutNobel
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor
2011
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Chemokines, cytokines and exosomes help tumors to shape inflammatory microenvironment
2016
Type I interferons in anticancer immunity
2015
Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress
2018
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Tumor microenvironment and cancer therapy resistance
2015
Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
2014
Orthogonal Design of Experiments for Engineering of Lipid Nanoparticles for mRNA Delivery to the Placenta
2023 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Systematic identification of signaling pathways with potential to confer anticancer drug resistance
2014
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
2018 StandoutScience
Mutated PPP1R3B Is Recognized by T Cells Used To Treat a Melanoma Patient Who Experienced a Durable Complete Tumor Regression
2013
Intratumoral administration of mRNA encoding a fusokine consisting of IFN-β and the ectodomain of the TGF-β receptor II potentiates antitumor immunity
2014
Immunity, inflammation, and cancer: an eternal fight between good and evil
2015
T cell exclusion, immune privilege, and the tumor microenvironment
2015 StandoutScience
Poly (γ-glutamic acid) based combination of water-insoluble paclitaxel and TLR7 agonist for chemo-immunotherapy
2014
IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade
2017 Standout
Neoantigens in cancer immunotherapy
2015 StandoutScience
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Adaptive Immune Resistance: How Cancer Protects from Immune Attack
2015
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Immune Checkpoint Blockade in Cancer Therapy
2015 Standout
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
2013
Works of Marcel Renn being referenced
Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
2014
MITF and c-Jun antagonism interconnects melanoma dedifferentiation with pro-inflammatory cytokine responsiveness and myeloid cell recruitment
2015
Autochthonous primary and metastatic melanomas in Hgf‐Cdk4R24C mice evade T‐cell‐mediated immune surveillance
2010
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation
2012 Nature
A Human In Vitro Whole Blood Assay to Predict the Systemic Cytokine Response to Therapeutic Oligonucleotides Including siRNA
2013
Complete Regression of Advanced Primary and Metastatic Mouse Melanomas following Combination Chemoimmunotherapy
2009